Enlivex Therapeutics Ltd. buy Liberte
Start price
03.10.20
/
50%
€11.30
Target price
04.11.21
-
Performance (%)
-43.36%
End price
20.07.21
€6.40
Summary
This prediction ended on 20.07.21 with a price of €6.40. The BUY prediction by Liberte for Enlivex Therapeutics Ltd. performed very badly with a performance of -43.36%. Liberte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | 14.013% | 14.013% | -19.369% | -77.168% |
| iShares Core DAX® | -0.121% | 2.507% | 16.129% | 61.530% |
| iShares Nasdaq 100 | 0.081% | -0.241% | 4.636% | 97.770% |
| iShares Nikkei 225® | -1.748% | 4.105% | 16.103% | 48.713% |
| iShares S&P 500 | -0.961% | -0.143% | 1.644% | 62.430% |
According to Liberte what are the pros and cons of Enlivex Therapeutics Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Liberte for this prediction
In the thread Enlivex Therapeutics Ltd. diskutieren
Buy Bio Blast Pharma Ltd